Many patients with kidney failure regret initiating dialysis

 

  • Discussing life expectancy and completing a living will may lessen likelihood of experiencing regret
  • In a study of adults with kidney failure treated with dialysis, 21% of patients reported regret that they decided to initiate dialysis.
  • Certain factors were linked with a higher likelihood of experiencing regret.

 

Washington, DC, USA (June 4, 2020) — Results from a new study indicate that many patients with kidney failure regret initiating dialysis, and those who choose dialysis to please their doctors or family members may be more likely to experience regret. The findings appear in an upcoming issue of CJASN.

Sometimes patients experience regret when they reflect on a decision they’ve made about their medical care, and this can negatively affect their quality of life. For patients with kidney failure who cannot receive a transplant and are contemplating dialysis, it’s important to have discussions with kidney specialists and other experts who can explain the impacts that dialysis may have on their lives.

Because few studies have examined regret in patients after they’ve started dialysis as a treatment for kidney failure, a team led by Fahad Saeed, MD (University of Rochester Medical Center) and Paul R. Duberstein, PhD (Rutgers School of Public Health) analyzed survey responses related to regret in patients receiving maintenance dialysis from 7 dialysis units in the Cleveland, Ohio area.

Eighty-two of 397 respondents (21%) reported regret that they decided to initiate dialysis. There were no significant demographic factors linked with regret. Regret was more common when patients reported choosing dialysis to please doctors or family members. Patients who reported discussing life expectancy with their doctors and those who had completed a living will were less likely to report regret that they started dialysis.

„Three strategies to mitigate regret in patients with kidney failure are: the public should be educated about alternatives to dialysis, such as conservative management or active medical management without dialysis; nephrologists should give patients and family members detailed information about life expectancy and quality of life with and without dialysis to help patients and family members decide whether to start dialysis; and patients should talk with their doctors about their life expectancy and complete a living will,“ said Dr. Saeed.

 

Study co-authors include Susan A. Ladwig, MPH, Ronald M. Epstein, MD, and Rebeca Monk, MD.

Disclosures: Dr. Saeed is a recipient of the University of Rochester CTSI KL2 award, Carl W. Gottschalk Research Scholar Grant and a grant by the Renal Research Institute. The authors reported no other financial disclosures.

The article, entitled „Dialysis Regret: Prevalence and Correlates,“ will appear online at http://cjasn.asnjournals.org/ on June 4, 2020, doi: 10.2215/CJN.13781119.

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries.

 

 


American Society of Nephrology, 04.06.2020 (tB).

Schlagwörter: ,

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…